← Back
Data updated: Mar 29, 2026
ADAPTIS
NeurologyImmunologyOncology
Generics
ADAPTIS is a generic drug manufacturer focused on Neurology, Immunology, Oncology.
1986
Since
17
Drugs
-
Trials
349
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 40%
2 drugs
Immunology 20%
1 drugs
Oncology 20%
1 drugs
Gastroenterology 20%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology
Amgen biotech
Oncology, Immunology, Gastroenterology, Neurology
Active (11)
Discontinued (6)
Company Info
- First Approval
- 1986-10-15
- Latest
- 2025-09-17
- Applications
- 19